{"disease":{"id":"lipoatrophy","name":"lipoatrophy"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03050749","title":"Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or Scars","phase":"NA","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Croma-Pharma GmbH","has_results":false},{"nct_id":"NCT03050723","title":"Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or Scars","phase":"NA","overall_status":"COMPLETED","enrollment_count":53,"lead_sponsor_name":"Croma-Pharma GmbH","has_results":false},{"nct_id":"NCT05776836","title":"Evaluation of HA Dermal Fillers in the Treatment of Pathological Facial Lipoatrophy","phase":"NA","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Symatese","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}